Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials

• Main Authors: Jiahui Yu (Author), Mengnan Li (Author), Boxu Ren (Author), Le Cheng (Author), Xiaoxiao Wang (Author), Zhaowu Ma (Author), Wei Peng Yong (Author), Xiaoguang Chen (Author), Lingzhi Wang (Author), Boon Cher Goh (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hepatocellular carcinoma (HCC) is a prevalent primary liver cancer, representing approximately 85% of cases. The diagnosis is often made in the middle and late stages, necessitating systemic treatment as the primary therapeutic option. Despite sorafenib being the established standard of care for adv...